Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma-Reference-Cited by-同舟云学术

Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma

Published:2018-11-10 Issue:3 Volume:21 Page:326-336
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Eisemann Tanja¹²,Costa Barbara¹,Harter Patrick N³⁴⁵,Wick Wolfgang⁴⁵⁶,Mittelbronn Michel³⁴⁵⁷⁸,Angel Peter¹^ORCID,Peterziel Heike¹⁹

Affiliation:

1. Division of Signal Transduction and Growth Control, DKFZ/ZMBH Alliance, Heidelberg, Germany

2. Faculty of Biosciences, University Heidelberg, Heidelberg, Germany

3. Institute of Neurology (Edinger-Institute), University Hospital Frankfurt, Goethe University, Frankfurt, Germany

4. German Cancer Consortium (DKTK), Heidelberg, Germany

5. German Cancer Research Center (DKFZ), Heidelberg, Germany

6. Department of Neurology, Heidelberg University Hospital and Clinical Cooperation Unit Neuro-oncology, National Center for Tumor Diseases, Heidelberg, Germany

7. Luxembourg Centre of Neuropathology, Luxembourg

8. Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg

9. Clinical Cooperation Unit Pediatric Oncology, DKFZ, Heidelberg, Germany and German Consortium for Translational Cancer Research (DKTK)

Funder

Luxembourg National Research Fond

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/21/3/326/27886456/noy184.pdf

Reference33 articles.

1. Glioblastoma survival in the United States before and during the temozolomide era;Johnson;J Neurooncol,2012

2. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression;Mishima;Acta Neuropathol,2006

3. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors;Schacht;Am J Pathol,2005

4. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton;Wicki;Cancer Cell,2006

5. Podoplanin—a small glycoprotein with many faces;Ugorski;Am J Cancer Res,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDPN is associated with prognosis and immune heterogeneity of glioblastomas;Asian Journal of Surgery;2024-06

2. CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review;Biomedicines;2024-01-21

3. C-Type Lectin-like Receptor 2 Expression Is Decreased upon Platelet Activation and Is Lower in Most Tumor Entities Compared to Healthy Controls;Cancers;2023-11-22

4. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM;npj Precision Oncology;2022-12-27

5. Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids;IEEE Transactions on Medical Imaging;2022-12